# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(3.12) per share which missed the analyst consensus estimate of ...
Shares of Alcoa Corporation (NYSE: AA) rose sharply in today’s pre-market trading after the company reported better-than-expec...
Tenax Therapeutics (NASDAQ:TENX) reported quarterly losses of $(11.84) per share which missed the analyst consensus estimate of...
Shares of Fangdd Network Group Ltd. (NASDAQ: DUO) rose sharply in today’s pre-market trading after the company announced its 2...
Roth MKM analyst Jonathan Aschoff reiterates Tenax Therapeutics (NASDAQ:TENX) with a Buy and maintains $30 price target.